On the contrary, the up-regulation or activation of intracellular GPX4 level can induce cell resistance to ferroptosis, suppress the therapeutic effects of drugs, and finally result in tumor resistance to chemotherapeutics [11]. The gene discussed is GPX4; the disease is neoplasm.